Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID-19: Challenges in Pharmacoepidemiologic Research
J Clin Pharmacol
.
2023 May;63(5):521-525.
doi: 10.1002/jcph.2195.
Epub 2023 Jan 9.
Authors
Renato Ferreira da Silva
1
2
3
,
Ana Marta Silva
1
2
3
,
Manuela Morato
4
,
Inês Ribeiro-Vaz
1
2
3
,
Jorge Junqueira Polónia
1
3
5
Affiliations
1
Porto Pharmacovigilance Centre, Faculty of Medicine of the University of Porto, Porto, Portugal.
2
Department of Community Medicine, Health Information and Decision, Faculty of Medicine of the University of Porto, Portugal.
3
CINTESIS - Center for Health Technology and Services Research, Porto, Portugal.
4
LAQV/REQUIMTE, Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy of the University of Porto, Porto, Portugal.
5
Department of Medicine, Faculty of Medicine of the University of Porto, Porto, Portugal.
PMID:
36519976
PMCID:
PMC9878095
DOI:
10.1002/jcph.2195
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Antiviral Agents* / therapeutic use
COVID-19*
Humans
Pharmacoepidemiology
Research Design
Substances
Antiviral Agents